B. P. Branchaud, H. S. Blanchette / Tetrahedron Letters 43 (2002) 351–353
353
(77% e.e.) with BF3·Et2O in CH2Cl2 at 0°C followed by
warming to room temperature with stirring for 16 h led
to enantiomerically enriched 12, in 35% isolated yield
after radial chromatography.11 Enantiomerically
enriched 12 was found to have 75% e.e. by chiral HPLC
analysis.18 Thus, this reaction proceeded with 97%
stereospecificity.8 Although this reaction proceeded in
lower yield than the racemic one, the stereospecificity
for the cyclization reaction is high.
2. Toshimitsu, A.; Hirosawa, C.; Tanimoto, S. Tetrahedron
Lett. 1991, 32, 4317–4320.
3. Toshimitsu, A.; Hirosawa, C.; Tamao, K. Tetrahedron
1994, 50, 8997–9008.
4. Toshimitsu, A.; Abe, H.; Hirosawa, C.; Tanimoto, S. J.
Chem. Soc., Chem. Commun. 1992, 284–285.
5. Toshimitsu, A.; Abe, H.; Hirosawa, C.; Tamao, K. J.
Chem. Soc., Perkin Trans. 1 1994, 3465–3471.
6. Toshimitsu, A.; Hirosawa, C.; Tanimoto, S. Chem. Lett.
1992, 239–242.
Enantiomerically enriched hydroxysulfide 9 was pre-
pared by Sharpless asymmetric dihydroxylation of 7
using AD-mix-b, monotosylation of the resulting diol,
then reaction of the tosylate with NaSPh (Scheme 3) to
provide enantiomerically enriched 9 in 12% isolated
overall yield, after radial chromatography of 9, for
three steps from 7.14 Enantiomerically enriched 9 was
found to have 76% e.e. by chiral HPLC analysis.18
Treatment of enantiomerically enriched 9 (76% e.e.)
with BF3·Et2O in CH2Cl2 at 0°C followed by warming
to room temperature with stirring for 16 h led to
enantiomerically enriched 13 in 98% isolated yield after
radial chromatography.15 Enantiomerically enriched 13
was found to have 76% e.e. by chiral HPLC analysis.18
Thus, this reaction proceeded with ꢀ100% stereospe-
cificity.8 This reaction proceeded in high chemical yield
and high stereospecificity.
7. Toshimitsu, A.; Hirosawa, C.; Tamao, K. Synlett 1996,
465–467.
8. Stereospecificity is defined in Ref. 7 as follows:
stereospecificity=[(% enantiomeric excess of product/%
enantiomeric excess of reactant)×100].
9. Elings, J. A.; Downing, R. S.; Sheldon, R. A. Eur. J. Org.
Chem. 1999, 4, 837–846.
10. Compound 8 is a known compound but has not been
previously used for episulfonium ion cyclizations. See: (a)
Hosomi, A.; Ogata, K.; Hoashi, K.; Kora, S.; Tominaga,
Y. Chem. Pharm. Bull. 1988, 36, 3736–3738; (b) Takeda,
T.; Furukawa, H.; Fujimori, M.; Suzuki, K.; Fujiwara, T.
Bull. Chem. Soc. Jpn. 1984, 57, 1863–1869.
11. Compound 12 is a known compound but has not been
prepared previously using episulfonium ion cyclizations.
See: (a) Reich, H. J.; Peake, S. L. J. Am. Chem. Soc.
1978, 100, 4888–4889; (b) Eisenbraun, E. J.; Bansal, R.
C.; Hertzler, D. V.; Duncan, W. P.; Flanagan, P. W. K.;
Manning, M. C. J. Org. Chem. 1970, 35, 1265–1271.
12. Sih, N.; Pines, H. J. Org. Chem. 1965, 30, 1462–1466.
13. Adamczyk, M.; Johnson, D. D.; Reddy, R. E. Tetra-
hedron 1999, 55, 63–88.
These results demonstrate that cyclizations of phenyl
episulfonium ions onto unactivated (or lightly acti-
vated) benzene rings can be highly stereoselective (97–
100% stereospecificity).8 Since it is easy to prepare
b-hydroxysulfides from epoxides or vicinal diols, the
results also illustrate how episulfonium ion chemistry
can be used to convert the products of contemporary
asymmetric epoxidation and dihydroxylation reactions
into more complex chiral enantiomerically enriched
products.
14. The S enantiomer of 9 is a known compound. See:
Fujisawa, T.; Itoh, T.; Nakai, M.; Sato, T. Tetrahedron
Lett. 1985, 26, 771–774.
15. Compound 13 is a new compound and was characterized
1
by H NMR, 13C NMR and IR.
16. The vicinal diol prepared by Sharpless asymmetric dihy-
droxylation of 6 using AD-mix-b is known (see Ref. 17).
The S enantiomer of the monotosylate derived from the
vicinal diol is a known compound. See: Klunder, J. M.;
Onami, T.; Sharpless, K. B. J. Org. Chem. 1989, 54,
1295–1304.
Acknowledgements
17. Wang, Z.-M.; Zhang, X.-L.; Sharpless, K. B. Tetrahedron
This work was supported by the National Science
Foundation and the Elsa U. Pardee Foundation for
Cancer Research.
Lett. 1993, 34, 2267–2270.
18. All chiral HPLC analyses for 8, 9, 12, and 13 were run
using a Chiracel OD-H column from Daicel Chemical
Industries with 10–20% i-propyl alcohol/hexanes as sol-
vent with UV–vis spectrophotometric detection of peaks.
In each case, the corresponding racemic compounds,
prepared as shown in Scheme 2, were used as calibration
standards.
References
1. Harring, S. R.; Edstrom, E. D.; Livinghouse, T. Adv.
Heterocyclic Nat. Prod. Synth. 1992, 2, 299–376.